MIT HEALS and Deshpande Center Momentum Grants
MIT HEALS and Deshpande Center Momentum Grants fund innovative, interdisciplinary research in health, life sciences, genomic medicine, and AgriFood systems at the Massachusetts Institute of Technology.
Funder: Massachusetts Institute of Technology
Due Dates: January 30, 2026 (Genomic Medicines LOI) | March 6, 2026 (Genomic Medicines Full Proposal) | June 1, 2026 (HEALS Seed/Innovator/Breakthrough LOI) | June 30, 2026 (HEALS Seed/Innovator/Breakthrough Full Proposal) | August 31, 2026 (ATLAS LOI)
Funding Amounts: Up to $200,000/year per PI (Genomic Medicines); $100k–$200k/year per PI (Seed/Breakthrough); $50k–$500k/project (ATLAS); most grants 1–2 years.
Summary: Supports transformative, interdisciplinary research and technology development in health, life sciences, and AgriFood systems at MIT.
Key Information: No funds may be distributed to non-MIT collaborators; permanent MIT PI status required for most programs.
Description
The MIT HEALS and Deshpande Center Momentum Grants are a suite of collaborative funding opportunities designed to accelerate high-impact, interdisciplinary research and innovation in health, life sciences, genomic medicine, and AgriFood systems. These grants aim to catalyze breakthroughs that address critical scientific, technological, and societal challenges, with particular emphasis on bold, cross-disciplinary approaches, novel technologies, and data sharing. Programs under this umbrella include the Genomic Medicines Accelerator Fund, HEALS Seed/Innovator/Breakthrough Grants, and the ATLAS RFP, each with specific focus areas and funding structures.
